Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
CC transcript
Quarterly results
Appointed director

Viracta Therapeutics, Inc. (VIRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2023 3 Cohen Darrel P. (Chief Medical Officer) has filed a Form 3 on Viracta Therapeutics, Inc.
06/09/2023 4 Simon Barry J. (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Rubino Stephen (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Murphy Samuel Lafayette (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 DARCY THOMAS E (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Chung Jane (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Borellini Flavia (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
06/09/2023 4 Barlow Jane F (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
05/26/2023 4 ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 25,219 restricted stock units @ $0
05/26/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,035 restricted stock units @ $0
05/26/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,635 shares @ $1.4196, valued at $5.2k
Exercised 6,889 restricted stock units @ $0
03/17/2023 4 Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 400,000 options to buy @ $1.65, valued at $660k
03/17/2023 4 Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.65, valued at $247.5k
03/17/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $1.65, valued at $330k
02/28/2023 4 ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 25,219 restricted stock units @ $0
02/28/2023 4 Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 2,156 shares @ $1.6812, valued at $3.6k
Exercised 4,127 restricted stock units @ $0
02/28/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,034 restricted stock units @ $0
02/28/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,599 shares @ $1.6812, valued at $6.1k
Exercised 6,889 restricted stock units @ $0
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,034 restricted stock units @ $0
11/29/2022 4 ROYSTON IVOR (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 25,219 restricted stock units @ $0
09/19/2022 4 Rothera Mark (President and CEO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 1,375,000 options to buy @ $5.21, valued at $7.2M
09/19/2022 3 Rothera Mark (President and CEO) has filed a Form 3 on Viracta Therapeutics, Inc.
08/29/2022 4 Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 2,190 shares @ $4.0118, valued at $8.8k
Exercised 4,127 restricted stock units @ $0
08/29/2022 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,034 restricted stock units @ $0
08/29/2022 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,655 shares @ $4.0162, valued at $14.7k
Exercised 6,889 restricted stock units @ $0
08/29/2022 4 ROYSTON IVOR (CEO & President) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 13,379 shares @ $4.0105, valued at $53.7k
Exercised 25,219 restricted stock units @ $0
08/11/2022 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 30,282 options to buy @ $3.69, valued at $111.7k
08/11/2022 4 Chung Jane (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 80,000 options to buy @ $3.69, valued at $295.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy